Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r9data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

arcoris bio AG

History from 14 Feb 2022

UID
CHE-192.823.524
Legal form
AG
Canton
ZH
Founded
14 Feb 2022
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 221k
55k110k166k221k17 Jul 2023 · CHF 117k23 Apr 2024 · CHF 129k10 Sep 2025 · CHF 176k3 Oct 2025 · CHF 184k15 Sep 2026 · CHF 221k202420252026
  • shares

Record

  1. SHAB published 17 Feb 2022 · legal date 14 Feb 2022

    Company formed

    Founded 14 Feb 2022

    SHAB HR01-1005407967 ↗

  2. SHAB published 14 Feb 2023 · legal date 2 Feb 2023

    Capital band adopted

    SHAB HR02-1005677740 ↗

  3. SHAB published 17 Jul 2023 · legal date 5 Jul 2023

    Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    100’000 → 117’389
    Shares
    100’000 → 117’389
    New shares, % of post-step shares
    14.8% (17’389 new)
    SHAB HR02-1005796788 ↗

  4. SHAB published 23 Apr 2024 · legal date 11 Apr 2024

    Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    117’389 → 129’152
    Shares
    117’389 → 129’152
    New shares, % of post-step shares
    9.1% (11’763 new)
    SHAB HR02-1006015443 ↗

  5. SHAB published 10 Sep 2025 · legal date 3 Sep 2025

    Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    129’152 → 176’225
    Shares
    129’152 → 176’225
    New shares, % of post-step shares
    26.7% (47’073 new)
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.85 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006429133 ↗

  6. SHAB published 10 Sep 2025 · legal date 3 Sep 2025

    Capital band adopted

    SHAB HR02-1006429133 ↗

  7. SHAB published 3 Oct 2025 · legal date 18 Sep 2025

    Capital increase

    Capital increased · undecided

    Paid in cash

    Nominal capital
    176’225 → 184’051
    Shares
    176’225 → 184’051
    New shares, % of post-step shares
    4.3% (7’826 new)
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.55 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006448330 ↗

  8. SHAB published 15 Sep 2026 · legal date 2 Sep 2026

    Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    184’051 → 220’671
    Shares
    184’051 → 220’671
    New shares, % of post-step shares
    16.6% (36’620 new)
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.78 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006756239 ↗

Published by 8 Oct 2026